An essential role for gp130 in neointima formation following arterial injury
about
Src-dependent STAT-3-mediated expression of monocyte chemoattractant protein-1 is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migrationNovel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phasRegulation of resistin by cyclic mechanical stretch in cultured rat vascular smooth muscle cellsSuppression of JAK2/STAT3 signaling reduces end-to-end arterial anastomosis induced cell proliferation in common carotid arteries of ratsMicroRNA-150 aggravates H2O2-induced cardiac myocyte injury by down-regulating c-myb geneStat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice.Cyclin D1 is a bona fide target gene of NFATc1 and is sufficient in the mediation of injury-induced vascular wall remodeling.Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formationAdipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.IL-6 in diabetes and cardiovascular complications.Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation.15-Lipoxygenase-1-enhanced Src-Janus kinase 2-signal transducer and activator of transcription 3 stimulation and monocyte chemoattractant protein-1 expression require redox-sensitive activation of epidermal growth factor receptor in vascular wall reNEXN is a novel susceptibility gene for coronary artery disease in Han ChineseEmerging translational approaches to target STAT3 signalling and its impact on vascular diseaseSTAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.Transcriptional regulation of the cyclin D1 gene at a glance.Suppression of activation of signal transducer and activator of transcription-5B signaling in the vessel wall reduces balloon injury-induced neointima formation.Protein kinase N1 is a novel substrate of NFATc1-mediated cyclin D1-CDK6 activity and modulates vascular smooth muscle cell division and migration leading to inward blood vessel wall remodelingMicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4.An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis.CREB-mediated IL-6 expression is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration.Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1.A role for Gab1/SHP2 in thrombin activation of PAK1: gene transfer of kinase-dead PAK1 inhibits injury-induced restenosis.An Interleukin-6 Receptor Antibody Suppresses Atherosclerosis in Atherogenic Mice.Effect of sinomenine on vascular smooth muscle cell dedifferentiation and neointima formation after vascular injury in mice.PPAR attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells
P2860
Q28565946-A4F9135B-492F-45EB-9E83-2CAB48F833B4Q28567562-2B1C4951-BF57-4153-820E-F19D2FEADE9EQ28573427-1DA6F251-64CE-4DB6-AD87-1EEF95121BD8Q28574197-47D8CF82-EF82-4981-ABEB-9AE862839B12Q28576030-C9650EB9-9E60-4F6E-A998-8FAFDAA21C95Q33559676-D20BBA66-5590-45E7-A162-56D079C72971Q33661435-5A118525-E725-4C4A-9F5A-4257F3266771Q33795723-8E07016A-AEC6-4F96-9FDB-153ACA09D7AAQ34002877-F502B2CB-894E-4245-9A21-77A2B8450D84Q34025142-708EED70-9AC6-46AC-ABBC-2DF014779177Q34196423-9562A6BD-5382-4F78-B857-90DDB6DE4F24Q35063134-95AFE15E-146B-4632-8EC6-0959F9B63378Q35069996-03442D4E-DE62-44FA-B2B5-E207BC759B89Q35580177-89B1AF4B-08F7-41F9-AF1C-8F79B35D6939Q35925825-5412A55E-7FFF-4E58-B3AF-3D3C63DD0C90Q35985157-482E17E5-C512-467E-B058-F069E30EC3FAQ36007499-1EAFB87B-A494-49B6-9B14-7AA328DFC18CQ36332889-0AE23471-24D0-4CB0-B18E-99AB60219B06Q36673482-DEC437DF-669E-4ACA-8AED-BFC2C6A4E307Q36713529-CA6389A6-7200-4DE4-9050-F9A5B08A9E27Q37299808-2A0B0568-F04F-4FC8-8155-221A17CD4D1AQ38833487-D803A61C-4043-449B-B033-6A6ABF5B7D7DQ42926016-A4292180-B98F-4358-ACFE-264D58AF5049Q47220016-3DBA8D99-9919-4E94-9B71-1BA6BEFE421FQ53139750-6EB53002-84A9-47DB-8593-BA57CBE25D79Q57892049-D6B017B0-AEA1-466C-9348-A4D54EB5C5F5
P2860
An essential role for gp130 in neointima formation following arterial injury
description
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im März 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/03/30)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/03/30)
@nl
наукова стаття, опублікована в березні 2007
@uk
مقالة علمية (نشرت في 30-3-2007)
@ar
name
An essential role for gp130 in neointima formation following arterial injury
@ast
An essential role for gp130 in neointima formation following arterial injury
@en
An essential role for gp130 in neointima formation following arterial injury
@nl
type
label
An essential role for gp130 in neointima formation following arterial injury
@ast
An essential role for gp130 in neointima formation following arterial injury
@en
An essential role for gp130 in neointima formation following arterial injury
@nl
prefLabel
An essential role for gp130 in neointima formation following arterial injury
@ast
An essential role for gp130 in neointima formation following arterial injury
@en
An essential role for gp130 in neointima formation following arterial injury
@nl
P2093
P1433
P1476
An essential role for gp130 in neointima formation following arterial injury
@en
P2093
Arun K. Bajpai
Chunxiang Zhang
Farhan Rizvi
Gadiparthi N. Rao
Huiqing Cao
Kevin W. Harris
Manjula Karpurapu
Nagadhara Dronadula
P304
P356
10.1161/01.RES.0000261350.61711.9E
P577
2007-03-30T00:00:00Z